Literature DB >> 12507783

TGF-beta 1 and IL-10 modulate IL-1 beta-induced membrane and soluble ICAM-1 in human myoblasts.

Mariapaola Marino1, Flavia Scuderi, Francesca Mannella, Emanuela Bartoccioni.   

Abstract

We have previously shown that interleukin (IL)-1 beta and other inflammatory cytokines are able to induce the expression of membrane and soluble intercellular adhesion molecule (ICAM)-1 on human myoblasts. In this paper we found that IL-10 and transforming growth factor (TGF)-beta 1 are able to prevent IL-1 beta-induced membrane and soluble ICAM-1 protein expression on human myoblasts, with different time courses. The effect of both cytokines is associated to a reduction in ICAM-1 mRNA. Our findings suggest that IL-10 and TGF-beta 1 are able to influence the inflammatory process in muscle tissue at least in part by means of control of membrane and soluble ICAM-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507783     DOI: 10.1016/s0165-5728(02)00399-5

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  3 in total

1.  Myogenic Cell Expression of Intercellular Adhesion Molecule-1 Contributes to Muscle Regeneration after Injury.

Authors:  Ryan A Martin; Kole H Buckley; Drew C Mankowski; Benjamin M Riley; Alena N Sidwell; Stephanie L Douglas; Randall G Worth; Francis X Pizza
Journal:  Am J Pathol       Date:  2020-07-08       Impact factor: 4.307

2.  Intercellular adhesion molecule-1 augments myoblast adhesion and fusion through homophilic trans-interactions.

Authors:  Francis X Pizza; Ryan A Martin; Evan M Springer; Maxwell S Leffler; Bryce R Woelmer; Isaac J Recker; Douglas W Leaman
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

3.  Skeletal muscle cells express ICAM-1 after muscle overload and ICAM-1 contributes to the ensuing hypertrophic response.

Authors:  Christopher L Dearth; Qingnian Goh; Joseph S Marino; Peter A Cicinelli; Maria J Torres-Palsa; Philippe Pierre; Randall G Worth; Francis X Pizza
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.